These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases]. Molgó M, Carreño N, Hoyos-Bachiloglu R, Andresen M, González S. Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180 [Abstract] [Full Text] [Related]
16. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China. Sun J, Liu J, Gong QL, Ding GZ, Ma LW, Zhang LC, Lu Y. Drug Des Devel Ther; 2014 Mar; 8():2539-47. PubMed ID: 25548516 [Abstract] [Full Text] [Related]
17. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maître B, Revuz J, Bagot M, Roujeau JC. Br J Dermatol; 2010 Oct; 163(4):847-53. PubMed ID: 20500799 [Abstract] [Full Text] [Related]
18. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study. Zhang J, Lu CW, Chen CB, Wang CW, Chen WT, Cheng B, Ji C, Chung WH. J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514 [Abstract] [Full Text] [Related]
19. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, Shear NH, Koren G, Shannon MW, Garcia-Bournissen F. Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829 [Abstract] [Full Text] [Related]